Literature DB >> 2146314

Tuberculous peritonitis: a study comparing cirrhotic and noncirrhotic patients.

J M Aguado1, F Pons, F Casafont, G San Miguel, R Valle.   

Abstract

Tuberculous peritonitis is a rare disease, which often goes unrecognized because of the subtle clinical clues and its insidous onset. We retrospectively analyzed the records of 37 cases of tuberculous peritonitis diagnosed over a 15-year period, and compared the clinical and diagnostic features of cirrhotic and noncirrhotic patients. In cirrhotic patients, tuberculous peritonitis can simulate ascites from liver disease or spontaneous bacterial peritonitis. The diagnosis is difficult in these patients because the ascitic fluid may not be of the exudative type as a result of the low albumin level in serum, and lymphocytes do not predominate in all cases. Adenosine deaminase (ADA) activity in ascitic fluid was elevated (higher than 40 U/L) in all 11 patients (four patients with hepatic cirrhosis). The time required to achieve a correct diagnosis was significantly longer in cirrhotic than in noncirrhotic patients. The overall mortality was 13%, with deaths occurring exclusively among cirrhotic patients. We emphasize that tuberculous peritonitis in cirrhotic patients can present an atypical picture. A considerable element of suspicion is necessary.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146314

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

1.  Low gradient ascites: a seven-year course review.

Authors:  Fariborz Mansour-Ghanaei; Afshin Shafaghi; Amir-Hossein Bagherzadeh; Mohammad-Sadegh Fallah
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

2.  Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.

Authors:  Edwin S L Chan; Maria Carmen Montesinos; Patricia Fernandez; Avani Desai; David L Delano; Herman Yee; Allison B Reiss; Michael H Pillinger; Jiang-Fan Chen; Michael A Schwarzschild; Scott L Friedman; Bruce N Cronstein
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

Review 3.  Current concepts in the management of tuberculosis.

Authors:  Irene G Sia; Mark L Wieland
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

4.  Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.

Authors:  Yi-Jun Liao; Chun-Ying Wu; Shou-Wu Lee; Chia-Ling Lee; Sheng-Shun Yang; Chi-Sen Chang; Teng-Yu Lee
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 5.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Miliary tuberculosis in a patient with end-stage liver disease.

Authors:  Victoria Poplin; Brent Harbaugh; Matthias Salathe; Nathan C Bahr
Journal:  Cleve Clin J Med       Date:  2020-10-01       Impact factor: 2.321

Review 7.  Abdominal tuberculosis.

Authors:  V K Kapoor
Journal:  Postgrad Med J       Date:  1998-08       Impact factor: 2.401

8.  Differentiation of tuberculous peritonitis from peritonitis carcinomatosa without surgical intervention.

Authors:  Muhsin Kaya; Mehmet A Kaplan; Abdurrahman Isikdogan; Yusuf Celik
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

9.  Peritoneal tuberculosis presenting with portal vein thrombosis and transudative Ascites - a diagnostic dilemma: case report.

Authors:  Ushani Mayurika Wariyapperuma; Champa Indrani Welikala Jayasundera
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

10.  Chylous ascites in a patient with an overlap syndrome: a surprising response to rituximab.

Authors:  Alexandra Daniel; Gianluca Bagnato; Edward Vital; Francesco Del Galdo
Journal:  BMJ Case Rep       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.